Cargando…

Therapeutic MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets

The COVID-19 pandemic is having a catastrophic impact on human health. Widespread community transmission has triggered stringent distancing measures with severe socioeconomic consequences. Gaining control of the pandemic will depend on interruption of transmission chains until protective herd immuni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, Robert M., Wolf, Josef D., Plemper, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553152/ https://www.ncbi.nlm.nih.gov/pubmed/33052328 http://dx.doi.org/10.21203/rs.3.rs-89433/v1

Ejemplares similares

Therapeutically Administered Ribonucleoside Analogue MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets
por: Cox, Robert M., et al.
Publicado: (2020)

Progress Toward a Large-Scale Synthesis of Molnupiravir (MK-4482, EIDD-2801) from Cytidine
por: Ahlqvist, Grace P., et al.
Publicado: (2021)

Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2
por: Holman, Wendy, et al.
Publicado: (2021)

SARS-CoV-2 Infection is Effectively Treated and Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2021)

A High‐Yielding Synthesis of EIDD‐2801 from Uridine
por: Steiner, Alexander, et al.
Publicado: (2020)

Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model
por: Johnson, Dylan M., et al.
Publicado: (2023)

Short Synthesis of Molnupiravir (EIDD-2801) via a Thionated Uridine Intermediate
por: Dey, Raghunath, et al.
Publicado: (2021)

Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2020)

Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
por: Qin, Zhen, et al.
Publicado: (2021)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2020)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2021)

Conversion of N-acyl amidines to amidoximes: a convenient synthetic approach to molnupiravir (EIDD-2801) from ribose
por: Ahmed, Ajaz, et al.
Publicado: (2021)

Correction: Conversion of N-acyl amidines to amidoximes: a convenient synthetic approach to molnupiravir (EIDD-2801) from ribose
por: Ahmed, Ajaz, et al.
Publicado: (2022)

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
por: Kim, Young-Il, et al.
Publicado: (2020)

Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
por: Cox, Robert M., et al.
Publicado: (2021)

Transmission of SARS-CoV-2 from Human to Domestic Ferret
por: Račnik, Jožko, et al.
Publicado: (2021)

SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study
por: Schlottau, Kore, et al.
Publicado: (2020)

No indication for SARS-CoV-2 transmission to pet ferrets, in five cities in Poland, 2021 - antibody testing among ferrets living with owners infected with SARS-CoV-2 or free of infection
por: Kaczorek-Łukowska, Edyta, et al.
Publicado: (2023)

Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2020)

Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2021)

Therapeutics in Ferrets
por: Williams, Bruce H.
Publicado: (2000)

The SARS-CoV ferret model in an infection–challenge study
por: Chu, Yong-Kyu, et al.
Publicado: (2008)

Ferrets are valuable models for SARS-CoV-2 research
por: Ciurkiewicz, Malgorzata, et al.
Publicado: (2022)

Ferrets: A powerful model of SARS-CoV-2
por: Zhao, Yan, et al.
Publicado: (2023)

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication
por: Sourimant, Julien, et al.
Publicado: (2021)

Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
por: Cox, Robert M., et al.
Publicado: (2023)

Technical note - elliptic pick up C-2801-50-1
por: Oreberg, P E
Publicado: (1987)

FERRETS
por: Wolf, Tiffany M.
Publicado: (2009)

Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection
por: Martins, Mathias, et al.
Publicado: (2022)

SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets
por: Huang, Ying, et al.
Publicado: (2022)

Characterisation and natural progression of SARS-CoV-2 infection in ferrets
por: Au, Gough G., et al.
Publicado: (2022)

Natural SARS-CoV-2 Infection in Kept Ferrets, Spain
por: Gortázar, Christian, et al.
Publicado: (2021)

Influenza Infection in Ferrets with SARS-CoV-2 Infection History
por: Vilas Boas de Melo, Caroline, et al.
Publicado: (2022)

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
por: Langendries, Lana, et al.
Publicado: (2021)

Ferrets as a model for tuberculosis transmission
por: Gupta, Tuhina, et al.
Publicado: (2022)

Mapping influenza transmission in the ferret model to transmission in humans
por: Buhnerkempe, Michael G, et al.
Publicado: (2015)

Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets
por: Kim, Young-Il, et al.
Publicado: (2021)

Age-dependent pathogenic characteristics of SARS-CoV-2 infection in ferrets
por: Kim, Young-Il, et al.
Publicado: (2022)

miR-4482 and miR-3912 aim for 3ʹUTR of ERG mRNA in prostate cancer
por: Mumtaz, Sidra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1spv6icsbedc4obpgeec09p111